Hosted on MSN59m
Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide UpdateHims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
What happened to this child is horrible. Reminds me, where are the FDA and CDC in dealing with this unnamed E. coli outbreak ...
The FDA plans to rehire around 300 people in total, according to four sources with secondhand knowledge of the situation, ...
A multistate outbreak of Listeria monocytogenes infections has been linked to Lyons ReadyCare and Sysco Imperial Frozen ...
The FDA announced that a food distributor is recalling all ReadyCare and Sysco Imperial Frozen Supplemental shakes, typically ...
Capricor Therapeutics filed a BLA for deramiocel, showing promising results in slowing cardiac dysfunction in DMD ...
A state legislator is moving to outlaw the sale of nicotine pouches, despite the federal Food and Drug Administration’s ...
WASHINGTON — The Trump administration has started quietly rehiring some of the Food and Drug Administration employees it ...
An Arizona company recalled the product in January over the possibility of it containing an undeclared allergen.
A New Jersey company is recalling a sweet dark chocolate treat after it was revealed it might have undeclared milk in it.
The Trump Administration is calling for a report “assess[ing] the prevalence of and threat" of several drugs, including stimulants used to treat ADHD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback